Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
BMJ
    January 2026

  1. CORRECTION: Exposure to sugar rationing in first 1000 days after conception and long term cardiovascular outcomes: natural experiment study.
    BMJ. 2026;392:s119.
    >> Share

    December 2025

  2. Correction: Ionising radiation and cardiovascular disease: systematic review and meta-analysis.
    BMJ. 2025;391:r2557.
    >> Share


  3. Redressing inequities in women's cardiovascular health.
    BMJ. 2025;391:r2617.
    >> Share

    November 2025
  4. TRUONG T, Ahmed M, Gamayata K, Arachi T, et al
    Redressing inequities in women's cardiovascular health.
    BMJ. 2025;391:r2365.
    >> Share


  5. EXPRESSION OF CONCERN: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial.
    BMJ. 2025;391:r2388.
    >> Share

    October 2025
  6. ATTAR A, Mirhosseini SA, Mathur A, Dowlut S, et al
    Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).
    BMJ. 2025;391:e083382.
    >> Share

  7. ZHENG J, Zhou Z, Huang J, Tu Q, et al
    Exposure to sugar rationing in first 1000 days after conception and long term cardiovascular outcomes: natural experiment study.
    BMJ. 2025;391:e083890.
    >> Share

    September 2025
  8. ZHANG J, Liu X, Xu Y
    Cardiovascular toxicity risks in treating EGFR-mutated lung cancer.
    BMJ. 2025;390:r1834.
    >> Share

  9. MA Z, Cao F, Liao M, Min R, et al
    Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis.
    BMJ. 2025;390:e082834.
    >> Share

  10. BOWIE K
    Clopidogrel better than aspirin for preventing heart attack and stroke in patients with coronary artery disease, study finds.
    BMJ. 2025;390:r1844.
    >> Share

    August 2025
  11. AGARWAL A, Mustafa R, Manja V, Agoritsas T, et al
    Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline.
    BMJ. 2025;390:e082071.
    >> Share

    July 2025
  12. PICCOLO R, Laino A, Vitale AP, Franzone A, et al
    Sex related differences in efficacy and safety of antithrombotic therapy in patients with coronary artery disease: systematic review and meta-analysis.
    BMJ. 2025;390:e082974.
    >> Share

  13. TAYAL U
    Sex differences in antithrombotic therapy for coronary artery disease.
    BMJ. 2025;390:r1560.
    >> Share

    June 2025
  14. GIACOPPO D, Gragnano F, Watanabe H, Kimura T, et al
    P2Y(12) inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials.
    BMJ. 2025;389:e082561.
    >> Share

  15. REDDY RK, Bansal R, Ardissino M
    Antiplatelet monotherapy after percutaneous coronary intervention.
    BMJ. 2025;389:r1089.
    >> Share

    May 2025
  16. ZHANG X, Wang S, Zhou X, Tang Y, et al
    A village doctor-led mobile health intervention for cardiovascular risk reduction in rural China: cluster randomised controlled trial.
    BMJ. 2025;389:e082765.
    >> Share

  17. JANSEN C, van der Palen J, Tabak M
    Using mobile health to reduce cardiovascular disease risk.
    BMJ. 2025;389:r972.
    >> Share

  18. BORLAND S
    Why are UK cardiovascular deaths in under 65s rising again?
    BMJ. 2025;389:r1015.
    >> Share


  19. Effects of Medicaid coverage on cardiovascular health outcomes.
    BMJ. 2025;389:r863.
    >> Share


  20. Heterogeneous effects of Medicaid coverage on cardiovascular risk factors: secondary analysis of randomized controlled trial.
    BMJ. 2025;389:r859.
    >> Share

    April 2025
  21. JIANG H
    No-touch vein harvesting in coronary artery bypass surgery.
    BMJ. 2025;389:r728.
    >> Share

  22. TIAN M, Wang X, Feng W, Wang H, et al
    No-touch versus conventional vein in coronary artery bypass grafting: three year follow-up of multicentre randomised PATENCY trial.
    BMJ. 2025;389:e082883.
    >> Share

    March 2025
  23. GAO C, Zhu B, Ouyang F, Wen S, et al
    Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label, assessor blind, non-inferiority trial.
    BMJ. 2025;388:e082945.
    >> Share

  24. BELLOLIO F, Gottlieb M, Body R, Than MP, et al
    Evaluating patients with chest pain in the emergency department.
    BMJ. 2025;388:r136.
    >> Share

  25. HAN J, Zhai W, Wu Z, Zhang Z, et al
    Care guided by tissue oxygenation and haemodynamic monitoring in off-pump coronary artery bypass grafting (Bottomline-CS): assessor blind, single centre, randomised controlled trial.
    BMJ. 2025;388:e082104.
    >> Share

    February 2025
  26. YONIS H, Lokkegaard E, Kragholm K, Granger CB, et al
    Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study.
    BMJ. 2025;388:e082801.
    >> Share

  27. WISE J
    Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reports.
    BMJ. 2025;388:r287.
    >> Share

    January 2025
  28. HU W, Tao C, Wang L, Chen Z, et al
    Intra-arterial tenecteplase after successful endovascular recanalisation in patients with acute posterior circulation arterial occlusion (ATTENTION-IA): multicentre randomised controlled trial.
    BMJ. 2025;388:e080489.
    >> Share

    November 2024
  29. JOHANSSON T, Karlsson T, Bliuc D, Schmitz D, et al
    Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial.
    BMJ. 2024;387:e078784.
    >> Share

  30. MAHASE E
    Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog finds.
    BMJ. 2024;387:q2518.
    >> Share

    October 2024

  31. Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study.
    BMJ. 2024;387:q2381.
    >> Share

  32. LU J, Xu Y, Bi Y, Wang T, et al
    Reducing inequity through tackling social determinants of cardiovascular diseases in China.
    BMJ. 2024;387:e079197.
    >> Share

    September 2024
  33. INOUE K, Athey S, Baicker K, Tsugawa Y, et al
    Heterogeneous effects of Medicaid coverage on cardiovascular risk factors: secondary analysis of randomized controlled trial.
    BMJ. 2024;386:e079377.
    >> Share

  34. YANG C, Tebbutt SJ
    Effects of Medicaid coverage on cardiovascular health outcomes.
    BMJ. 2024;386:q1807.
    >> Share

    August 2024
  35. MENG R, Wang W, Huang T, Zhan S, et al
    Tackling social and behavioural risk factors for cardiovascular diseases in Chinese women.
    BMJ. 2024;386:e078638.
    >> Share

  36. MAHASE E
    Incidence of cardiovascular events was lower after covid-19 vaccination, study finds.
    BMJ. 2024;386:q1732.
    >> Share

    July 2024
  37. IACOBUCCI G
    Semaglutide: UK regulator approves drug for prevention of cardiovascular events.
    BMJ. 2024;386:q1660.
    >> Share

    June 2024

  38. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73).
    BMJ. 2024;385:q1450.
    >> Share

  39. CONRAD N, Molenberghs G, Verbeke G, Zaccardi F, et al
    Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study.
    BMJ. 2024;385:e078523.
    >> Share

  40. ZHU Y, Zhang W, Dimagli A, Han L, et al
    Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial.
    BMJ. 2024;385:e075707.
    >> Share

  41. SANDNER S
    Dual antiplatelet therapy after coronary artery bypass surgery.
    BMJ. 2024;385:q1083.
    >> Share


  42. Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:q1237.
    >> Share

    May 2024
  43. DYER C
    Former cardiovascular surgery lead is charged with 14 counts of sexual assault.
    BMJ. 2024;385:q1188.
    >> Share


  44. Cardiovascular toxicity of immune therapies for cancer.
    BMJ. 2024;385:q1197.
    >> Share


  45. Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:q1094.
    >> Share

  46. PALASKAS NL, Ali HJ, Koutroumpakis E, Ganatra S, et al
    Cardiovascular toxicity of immune therapies for cancer.
    BMJ. 2024;385:e075859.
    >> Share

  47. LI Z, Min XW, He PG, Zhang CH, et al
    Chest pain with diffuse ST segment elevation.
    BMJ. 2024;385:e078403.
    >> Share

    April 2024
  48. SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:e078242.
    >> Share

  49. MOK PLH, Carr MJ, Guthrie B, Morales DR, et al
    Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.
    BMJ. 2024;385:e076268.
    >> Share

  50. VINTER N, Cordsen P, Johnsen SP, Staerk L, et al
    Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study.
    BMJ. 2024;385:e077209.
    >> Share

    March 2024
  51. WONDERLING D, Mariani A, Samarasekera EJ, Wilkinson C, et al
    Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidance.
    BMJ. 2024;384:q637.
    >> Share

  52. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    >> Share

  53. TANNE JH
    Wegovy: FDA approves weight loss drug to cut cardiovascular risk.
    BMJ. 2024;384:q642.
    >> Share

    February 2024

  54. Exposure-response associations between chronic exposure to fine particulate matter and risks of hospital admission for major cardiovascular diseases: population based cohort study.
    BMJ. 2024;384:q517.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016